Gilead's Trodelvy suffers double whammy as failed bladder cancer trial raises flag over early deaths
Following a high-profile lung cancer setback in January, Gilead said Thursday Trodelvy also failed to move the needle in a bladder cancer study.
Source: fiercepharma.com